The Trisomy 21 Research Society has published a new research conducted by the T21RS to examine the risk of individuals with Down syndrome who have been diagnosed with COVID-19.
This work has been developed and undertaken by the T21RS COVID-19 taskforce, and supported by many stakeholder groups. The report contains information on symptoms, risk factors and outcomes following a COVID-19 diagnosis in people with Down syndrome.
The preprint report is open access and available here: https://www.medrxiv.org/content/10.1101/2020.11.03.20225359v1
The T21RS has also developed a series of infographics highlighting key findings which has been updated: https://www.t21rs.org/results-from-covid-19-and-down-syndrome-survey/